NCT03012750View on ClinicalTrials.gov

Angiosome Perfusion After Tibial Bypass

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

October 31, 2016

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Indocyanine Green

Perioperative application of 0.1 mg ICG per kg Body weight

All Listed Sponsors
lead

University Hospital Erlangen

OTHER

NCT03012750 - Angiosome Perfusion After Tibial Bypass | Biotech Hunter | Biotech Hunter